Search
Avalon Globocare Corp
ALBTAdd to Watchlist
0.282USD
0.0000.00%
Close 07-21 16:00（ET）Quotes delayed by 15 min
2.37MMarket Cap
LossP/E TTM
More Details of Avalon Globocare Corp Company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Avalon Globocare Corp Info
Ticker SymbolALBT
Company nameAvalon Globocare Corp
IPO dateFeb 22, 2016
CEOJin (David)
Number of employees5
Security typeOrdinary Share
Fiscal year-endFeb 22
Address4400 Route 9
CityFREEHOLD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07728
Phone17327804400
Websitehttps://www.avalon-globocare.com/
Ticker SymbolALBT
IPO dateFeb 22, 2016
CEOJin (David)
Company Executives of Avalon Globocare Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
2.51M
+90.49%
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
2.51M
+90.49%
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
FAQs
Who are the top five shareholders of Avalon Globocare Corp?
The top five shareholders of Avalon Globocare Corp are: Mr. Wenzhao (Daniel) Lu
How many institutions hold shares of Avalon Globocare Corp (ALBT)?
As of 2026Q1, 30 institutions hold shares of Avalon Globocare Corp, with a combined market value of approximately 83.03K, accounting for 1.00% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -43859.00.